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An 81-year old woman was referred to our emergency department
for antero-lateral STEMI. Hypertension pharmacologically treated and
no previous hospitalizations for cardiac problems. At admission, her
blood pressure was 120/70 mm Hg, pulse rate was 65 bpm, O2 Sat:
96%. GRACE risk score was 202 (high), CRUSADE bleeding score: 36
(moderate risk). The ECG showed normal sinus rhythm, Q-waves in DI
and aVL with ST-segment elevation (N0.1 mV) in DI, DII, DIII, aVF, V5,
V6 (Fig. 1A). The emergency echocardiogram revealed the akinesia of
mid-distal segments of inferior, anterolateral and inferolateral walls
and a moderately impaired left ventricle systolic function with ejection
fraction (EF) of 45–50%. According to the current ESC guidelines forDear Editor,
Themost frequent physiopathological substrate of ST-segment eleva-
tion myocardial infarction (STEMI) is total occlusion of an epicardial
coronary artery due to an occlusive thrombus underlying an atheroscle-
rotic plaque [1]. Rapid and complete coronary blood ﬂow restoration is
the mechanism underlying the beneﬁt of reperfusion therapy in patients
with STEMI. Percutaneous coronary intervention (PCI) restores a TIMI
grade ﬂow 3 in N90% of patients [2]. However, STEMI patients have a
high risk of intraprocedural thrombotic events (IPTEs) because of elevat-
ed thrombotic burden and prothrombotic milieu during the ischemic
event [3]. IPTEs occur more frequently in patients with STEMI than in
thosewith unstable angina or non-STEMI and are associatedwithmortal-
ity, bleeding and major adverse cardiac events (MACE) [4].
Distal embolization, slow ﬂow or no reﬂow and abrupt artery closure
are themost commoncomplicationsduring PCI for STEMI. Such complica-
tions tend to be life-threatening and to strongly increase the total
catheter-related mortality [4–6]. The occurrence of IPTEs is strongly
associated with a lower frequency of TIMI grade ﬂow 3 at the end of the
procedure and greatly adds to the procedure. Although the angiographic
presence of thrombus has been independently correlated to IPTEs, the
routinely use of aspiration thrombectomy is not associated with a reduc-
tion of their incidence. Despite the introduction of novel antiplatelet andis an open access article under the Cantithrombotic therapies, the occurrence of IPTEs during primary stenting
for STEMI is currently common (~1 in 8 patients).
STEMI [5] urgent PCI via radial artery puncture was performed. The
patient was pre-medicated with antiplatelets (300 mg of aspirin plus a
loading dose of ticagrelor 180 mg orally) and 5000 UI of unfractionated
heparin (UFH) i.v.
The angiograms showed acute occlusion of the proximal part of the
circumﬂex artery (LCX). We also noticed a myocardial bridge localized
in the middle segment of the left anterior descending coronary artery
(LAD). LAD and right coronary artery (RCA) were free from signiﬁcant
stenosis (Fig. 2A). Coronary angioplasty for the culprit lesion was
planned. A bolus of abciximab i.v. (0.25mg/Kg)was then administrated.
During the intervention procedure, we used a 6 F guiding catheter
(Cordis® XB 3.5 6 F) and two 0.014 in. guide wires (Abbott Vascular®,
Hi-Torque Balance Middleweight Universal 0.014″ 190 cm). After the
insertion of the ﬁrst guide wire to protect the left marginal artery and
the second guide in the LCXwe performed a pre-dilationwith a compli-
ant balloon (Cordis® EMPIRA™ 2.50mm×15mm139 cm). Then a bare
metal stent (Medtronic® Integrity BMS 2.75 mm × 22 mm) was im-
planted in the culprit lesion with complete recovery of patency in the
LCX and TIMI ﬂow grade 3 (Fig. 2B). The patient was, however, still
symptomatic for chest pain. The procedure was complicated by
hypotension, vomiting and subsequent respiratory arrest. Resuscitation
was started successfully. The check angiography showed total occlusion
of middle segment of LAD with thrombus (Fig. 2C). We immediately
started i.v. infusion of abciximab (0.125 μg/kg/min for 12 h). LAD was
opened with the passage of one guide wire and intracoronary infusion
of adenosine and angioplasty (POBA) in the middle part with the
balloon of the stent just released on LCX. Final TIMI ﬂow was grade 2
(Fig. 2D). The patient experienced immediate relief of chest pain butC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The admission twelve-lead electrocardiogram showed an ST elevation in inferior and lateral leads (A). Registration to the polygraph during PCI on circumﬂex (LCX) artery (B) and
after total occlusion of LADwith the patient in respiratory arrest associated with hypotension and sinus bradycardia (C). ECG post-PCI displays a good resolution of ST-segment elevation
(D).
Fig. 2. The angiogram shows acute occlusion of the proximal part of circumﬂex artery (arrow) and the LAD (ﬂash) well-developed and free from stenosis with the myocardial bridging
(star) in the middle part (A). Released bare metal stent (BMS) on LCX middle part (arrow). LAD to view (ﬂash) (B). Check angiogram indicated good ﬁnal result on LCX with TIMI 3
ﬂow (arrow) and the total occlusion of the proximal LAD (ﬂash) (C). Reopened of the LAD (ﬂash) with adenosine i.c. and guide wire and subsequent POBA in the middle part with ﬁnal
TIMI grade ﬂow 2 (D).
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(Killip II) which was successfully treated with nitrate and furosemide
i.v. The post-PCI electrocardiogram showed the resolution of ST-
segment elevation (Fig. 1D); the echocardiogram showed akinesia of
middle-distal segment of anterolateral, inferolateral and anterior walls
with EF 38%. The patient was discharged 10 days later on aspirin,
ticagrelor, beta blocker, statin, ARBs, spironolactone and lansoprazole,
with improved clinical conditions and completely asymptomatic in
the follow-up at a month. Last transthoracic echocardiogram showed
hypokinesis of the lateral and posterior walls and improved systolic
function (EF 50%).
Conclusion
In our knowledge, it is the ﬁrst case reported in literature of acute
and spontaneous total occlusion of LAD during PCI for STEMI in occlud-
ed LCX (culprit lesion). Indeed it has been previously published just a
similar case of iatrogenic (vs spontaneous) occlusion of a not culprit cor-
onary artery. In our case the complication is not due to themovement of
the guide wire or the balloon/stent in the vessel, nor to plaque rupture.
One of the possible causes of thrombus formation on LAD may be the
presence of myocardial bridging. Moreover, in our opinion it's impor-
tant to underlie that the occlusion occurred despite optimal medical
therapy (UHF, aspirin, ticagrelor and abciximab) suggested from the lat-
est guidelines [7]. This means that even the novel anti-platelets drugs
are not always so efﬁcient in the setting of acute coronary syndrome.Conﬂict of interest
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